163 related articles for article (PubMed ID: 27402288)
61. Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia.
Giménez N; Schulz R; Higashi M; Aymerich M; Villamor N; Delgado J; Juan M; López-Guerra M; Campo E; Rosich L; Seiffert M; Colomer D
Leukemia; 2020 Jan; 34(1):100-114. PubMed ID: 31197259
[TBL] [Abstract][Full Text] [Related]
62. Toll and Toll-like receptor signalling in development.
Anthoney N; Foldi I; Hidalgo A
Development; 2018 Apr; 145(9):. PubMed ID: 29695493
[TBL] [Abstract][Full Text] [Related]
63. Toll-like receptor signaling in cell proliferation and survival.
Li X; Jiang S; Tapping RI
Cytokine; 2010 Jan; 49(1):1-9. PubMed ID: 19775907
[TBL] [Abstract][Full Text] [Related]
64. Toll-like receptors in the pathogenesis of human B cell malignancies.
Isaza-Correa JM; Liang Z; van den Berg A; Diepstra A; Visser L
J Hematol Oncol; 2014 Aug; 7():57. PubMed ID: 25112836
[TBL] [Abstract][Full Text] [Related]
65. Tying the knot between cytokine and toll-like receptor signaling in gastrointestinal tract cancers.
Tye H; Jenkins BJ
Cancer Sci; 2013 Sep; 104(9):1139-45. PubMed ID: 23710764
[TBL] [Abstract][Full Text] [Related]
66. The Role of Toll and Nonnuclear NF-κB Signaling in the Response to Alcohol.
Atkinson NS
Cells; 2023 May; 12(11):. PubMed ID: 37296629
[TBL] [Abstract][Full Text] [Related]
67. Effects of Toll-like receptor signals in T-cell neoplasms.
Morrison C; Baer MR; Zandberg DP; Kimball A; Davila E
Future Oncol; 2011 Feb; 7(2):309-20. PubMed ID: 21345147
[TBL] [Abstract][Full Text] [Related]
68. Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies.
Kennedy R; Klein U
Cells; 2018 Oct; 7(11):. PubMed ID: 30380749
[TBL] [Abstract][Full Text] [Related]
69. The role of BAFF-R dysregulation in B-lymphoid lineage malignancies.
Pham LV; Ford RJ
Cell Cycle; 2011 Jan; 10(2):189-90. PubMed ID: 21239884
[No Abstract] [Full Text] [Related]
70. The evolution and origin of animal Toll-like receptor signaling pathway revealed by network-level molecular evolutionary analyses.
Song X; Jin P; Qin S; Chen L; Ma F
PLoS One; 2012; 7(12):e51657. PubMed ID: 23236523
[TBL] [Abstract][Full Text] [Related]
71. Toll-like receptors: lessons to learn from normal and malignant human B cells.
Chiron D; Bekeredjian-Ding I; Pellat-Deceunynck C; Bataille R; Jego G
Blood; 2008 Sep; 112(6):2205-13. PubMed ID: 18591383
[TBL] [Abstract][Full Text] [Related]
72. NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.
Grondona P; Bucher P; Schulze-Osthoff K; Hailfinger S; Schmitt A
Biomedicines; 2018 Mar; 6(2):. PubMed ID: 29587428
[TBL] [Abstract][Full Text] [Related]
73. Role of NFkappaB signaling in normal and malignant B cell development.
Sasaki Y; Schmidt-Supprian M; Derudder E; Rajewsky K
Adv Exp Med Biol; 2007; 596():149-54. PubMed ID: 17338183
[No Abstract] [Full Text] [Related]
74. B-cell malignancies: All roads lead to NF-κB activation.
Rosenquist R; Stamatopoulos K
Semin Cancer Biol; 2016 Aug; 39():1-2. PubMed ID: 27546288
[No Abstract] [Full Text] [Related]
75. Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies.
Sana I; Mantione ME; Angelillo P; Muzio M
Front Oncol; 2021; 11():651057. PubMed ID: 33869054
[TBL] [Abstract][Full Text] [Related]
76. Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.
Della-Valle V; Roos-Weil D; Scourzic L; Mouly E; Aid Z; Darwiche W; Lecluse Y; Damm F; Mémet S; Mercher T; Aoufouchi S; Nguyen-Khac F; Bernard OA; Ghamlouch H
Blood Cancer J; 2020 Mar; 10(3):38. PubMed ID: 32170099
[TBL] [Abstract][Full Text] [Related]
77. Holding the Inflammatory System in Check: TLRs and NLRs.
Holl EK; Allen IC; Martinez J
Mediators Inflamm; 2016; 2016():8156816. PubMed ID: 27642239
[No Abstract] [Full Text] [Related]
78. Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes.
Alexopoulos LG; Saez-Rodriguez J; Cosgrove BD; Lauffenburger DA; Sorger PK
Mol Cell Proteomics; 2010 Sep; 9(9):1849-65. PubMed ID: 20460255
[TBL] [Abstract][Full Text] [Related]
79. Developmental Biology. Death to the losers.
Morata G; Ballesteros-Arias L
Science; 2014 Dec; 346(6214):1181-2. PubMed ID: 25477441
[No Abstract] [Full Text] [Related]
80. Toll-like Receptors in Chronic Lymphocytic Leukemia.
Muzio M; Fonte E; Caligaris-Cappio F
Mediterr J Hematol Infect Dis; 2012; 4(1):e2012055. PubMed ID: 22973499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
